Phibro Animal Health (NASDAQ:PAHC) Cut to Buy at StockNews.com

StockNews.com downgraded shares of Phibro Animal Health (NASDAQ:PAHC) from a strong-buy rating to a buy rating in a research note released on Wednesday.

PAHC has been the topic of several other reports. Bank of America upped their price target on shares of Phibro Animal Health from $13.00 to $15.00 and gave the company an “underperform” rating in a report on Friday, August 30th. Barclays upped their target price on Phibro Animal Health from $13.00 to $20.00 and gave the stock an “underweight” rating in a research note on Tuesday, November 12th. Finally, JPMorgan Chase & Co. initiated coverage on Phibro Animal Health in a research report on Tuesday, September 10th. They set a “neutral” rating and a $22.00 price target for the company. Three research analysts have rated the stock with a sell rating, one has issued a hold rating and one has assigned a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $16.50.

Phibro Animal Health Stock Down 0.1 %

Shares of PAHC stock opened at $23.74 on Wednesday. The company has a debt-to-equity ratio of 1.81, a quick ratio of 1.69 and a current ratio of 3.23. Phibro Animal Health has a fifty-two week low of $9.49 and a fifty-two week high of $25.98. The firm has a market capitalization of $961.47 million, a PE ratio of 55.21, a P/E/G ratio of 0.61 and a beta of 0.51. The stock’s 50-day simple moving average is $23.16 and its 200-day simple moving average is $19.99.

Phibro Animal Health (NASDAQ:PAHC) last issued its quarterly earnings results on Wednesday, August 28th. The company reported $0.41 earnings per share for the quarter, topping the consensus estimate of $0.34 by $0.07. Phibro Animal Health had a net margin of 1.67% and a return on equity of 21.59%. The company had revenue of $273.16 million for the quarter, compared to the consensus estimate of $262.44 million. Equities analysts expect that Phibro Animal Health will post 1.61 earnings per share for the current year.

Phibro Animal Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, December 18th. Stockholders of record on Wednesday, November 27th will be given a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.02%. The ex-dividend date is Wednesday, November 27th. Phibro Animal Health’s dividend payout ratio (DPR) is presently 111.63%.

Insider Buying and Selling

In related news, Director E Thomas Corcoran acquired 5,000 shares of Phibro Animal Health stock in a transaction on Wednesday, September 4th. The stock was bought at an average cost of $20.02 per share, for a total transaction of $100,100.00. Following the completion of the transaction, the director now owns 25,000 shares of the company’s stock, valued at approximately $500,500. The trade was a 25.00 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through this link. 50.07% of the stock is currently owned by insiders.

Institutional Trading of Phibro Animal Health

Several institutional investors have recently modified their holdings of the stock. CWM LLC boosted its holdings in Phibro Animal Health by 89.8% in the 2nd quarter. CWM LLC now owns 2,188 shares of the company’s stock worth $37,000 after buying an additional 1,035 shares during the last quarter. nVerses Capital LLC purchased a new stake in shares of Phibro Animal Health during the third quarter worth approximately $70,000. Quantbot Technologies LP acquired a new position in Phibro Animal Health in the 3rd quarter valued at $70,000. Summit Securities Group LLC purchased a new position in Phibro Animal Health in the 2nd quarter valued at $83,000. Finally, China Universal Asset Management Co. Ltd. grew its holdings in shares of Phibro Animal Health by 63.7% during the third quarter. China Universal Asset Management Co. Ltd. now owns 3,912 shares of the company’s stock worth $88,000 after buying an additional 1,522 shares in the last quarter. Institutional investors and hedge funds own 99.34% of the company’s stock.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.